Woodline Partners LP Essa Pharma Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.44 $668,993 - $1.32 Million	382,282 New	382,282 $696,000
Q2 2022 Aug 15, 2022	SELL	$3.15 - $7.94 $1.18 Million - $2.98 Million	-375,084 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.18 - $14.44 $1.91 Million - $4.46 Million	-309,163 Reduced 45.18%	375,084 $2.32 Million
Q4 2021 Feb 14, 2022	BUY	$7.8 - $14.38 $3.96 Million - $7.29 Million	507,239 Added 286.56%	684,247 $9.72 Million
Q3 2021 Nov 15, 2021	BUY	$7.76 - $29.37 $1.37 Million - $5.2 Million	177,008 New	177,008 $1.42 Million

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.